Corporate News | 10/26/2006

RHÖN-KLINIKUM AG: Q3-2006 asnd 1-9/2006

RHÖN-KLINIKUM AG / Quarter Results/Results ForecastCorporate news transmitted by DGAP - a company of EquityStory AG.The issuer is solely responsible for the content of this announcement.
RHÖN-KLINIKUM AG, Bad Neustadt a.d.Saale• Q3 2006:- Revenue € 489.8 million / net consolidated profit € 24.5 million beforeconsideration of earnings share of minority owners EBITDA € 58.6 million /EBIT € 39.3 million• Q1 – Q3 2006:- Revenue € 1,427.9 million / net consolidated profit € 70.1 million beforeconsideration of earnings share of minority owners- EBITDA € 162.2 million / EBIT € 110.4 million- Growth in revenues and net consolidated profit underpin own forecast forfull-year result• As at reporting date (30 September 2006), the Group has 45 hospitals with14,690 beds/places at a total of 34 sites• A total of 1,037,764 patients were treated in the Group’s facilities inthe first nine months• 30,611 persons were employed with the Group as at 30 September 2006Bad Neustadt a.d.Saale, 26 October 2006 ----- The key results for Q3 2006published today by RHÖN-KLINIKUM AG, the listed hospital group withheadquarters in the Rhön, underpin the Group’s own forecasts for full-year2006: revenue of € 1.9 billion, net consolidated profit of € 93.0 million,earnings per share of € 1.72.In the third quarter of 2006 the Group generated revenues of € 489.8million (Q3 2005: € 356.4 million); looking at the first 9 months of 2006,revenues totalled € 1,427.9 million (9M 2005: € 1,044.7 million). “The36.7% rise in revenues in the first nine months of 2006 was mainly drivenby the first-time consolidation of Universitätsklinikum Gießen und MarburgGmbH contributing € 280.9 million (with 2,262 beds/places) from 1 February2006 and of two further hospitals, Frankenwaldklinik in Kronach andHeinz-Kalk-Krankenhaus in Bad Kissingen, adding revenue of € 30.0 million(with 398 beds/places, from 1 January 2006)”, said Dietmar Pawlik, CFO ofRHÖN-KLINIKUM AG. “Adjusted for accounting changes in connection with thepromotion of training and education, organic growth versus the same periodlast year was € 39.6 million (3.6%).”Net consolidated profit (before consideration of earnings share of minorityowners of 1.0 / previous year: 0.9 million) reached € 24.5 million in thethird quarter of 2006, a rise of 7.9% over the previous year’s figure of €22.7 million. With reference to the first nine months of 2006 the rise innet consolidated profit (before consideration of earnings share of minorityowners of 3.1 / previous year 3.2 million) was 4.5% (2006: € 70.1 million /last year: € 67.1 million). At the end of the first nine months, earningsper share stood at € 1.29 (previous year: € 1.23). The result for the firstnine months of 2006 was burdened by the € 6.5 million loss atUniversitätsklinikum Gießen und Marburg as expected, but this was offset byimprovements at the other hospitals.“The restructuring of Gießen/Marburg is moving ahead as planned”, explainedGerald Meder, chairman of the management board of UniversitätsklinikumGießen und Marburg GmbH and deputy chairman of the Board of Management ofRHÖN-KLINIKUM AG.In the third quarter of 2006 the key ratio EBITDA saw an improvement by16.3% to € 58.6 million (previous year: € 50.4 million) and EBIT gained10.1% to reach € 39.3 million (up from € 35.7 million the year before);earnings before tax (EBT) also improved, by 6.6% to € 33.8 million (vs. €31.7 million last year). Over the first nine months of 2006 EBITDA rose by8.8% to € 162.2 million (previous year: € 149.1 million), EBIT by 5.7% to €110.4 million (previous year: € 104.4 million) and EBT by roughly 4.0% to €96.3 million (previous year: € 92.6 million).The disproportionate rise in materials and consumables used recorded in thefirst nine months of 2006 (9M 2006: € 364.9 million / previous year: €259.6 million) as well as the strong rise in the employee benefits item (9M2006: € 842.7 million / previous year: € 589.1 million) are attributable tothe hospitals newly consolidated in the current financial year. These haverationalisation potential due to unfavourable structures versus ourlong-standing facilities.At 30 September 2006, cash and cash equivalents showed an increase by €86.9 million to € 224.6 million (previous year: € 137.7 million). The Groupenjoys sound financial structures. “We have continued to improve ourinternal financing strength”, explained Pawlik. “In the first nine monthsof financial year 2006, our operating cash flow rose 8.9% to € 122.0million (previous year: € 112.0 million).” In the third quarter of 2006,cash flow was € 43.8 million (€ 37.4 million).As at the reporting date 30 September 2006, the Group has 45 hospitals with14,690 beds/places at a total of 34 sites. In the first nine months a totalof 1,037,764 patients (previous year: 729,522; + 308,242) were treated inthe Group’s facilities, with the third quarter accounting for 360,149 ofthese (previous year: 241,687; + 118,462).At the reporting date 30 September 2006, the Group employed 30,611 persons(at 31 December 2005: 21,226), with 9,677 added by the facilities newlyconsolidated in 2006.“It is now known what impact the health reform will have. These burdens canbe compensated by numerous countermeasures. With its solution and industryexpertise RHÖN-KLINIKUM AG has repeatedly shown it knows how to respond tosuch changes.”, explained Wolfgang Pföhler, chairman of the Board ofManagement of RHÖN-KLINIKUM AG.Thanks to its future-oriented concepts – from the flow principle to theelectronic patient file as well as a new professional model for doctors –RHÖN-KLINIKUM AG enjoys a leading competitive position in the privatisationof university hospitals. RHÖN-KLINIKUM AG sees its strategy of profitablegrowth as wholly confirmed.***************************Brigitte SallweySallwey & PartnerTelemannstr. 18D-60322 Frankfurt/Main(+49)069 97 203 628DGAP 26.10.2006
Language: EnglishIssuer: RHÖN-KLINIKUM AG Salzburger Leite 1 97616 Bad Neustadt/ Saale DeutschlandPhone: +49 (0)9771 - 65-0Fax: +49 (0)9771 - 97 467E-mail: www.rhoen-klinikum-ag.comISIN: DE0007042301WKN: 704230Indices: MDAXListed: Amtlicher Markt in Frankfurt (Prime Standard), München; Freiverkehr in Berlin-Bremen, Düsseldorf, Hamburg, Stuttgart End of News DGAP News-Service